Advertisement

NLS Enzymatica

Agreement - January 20, 2021

Recipharm signs manufacturing agreement with Enzymatica

Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme. The agreement will involve an additional Recipharm production site in Pianezza, Italy, to support Enzymatica in increasing production volumes of ColdZyme to meet growing global demand. Both the facilities in Parets, Spain, and Pianezza, Italy, will be making additional investments to accommodate […]

Agreement - February 14, 2017

Enzymatica enters partnership agreement

Enzymatica enters into partnership agreement with STADA Arzneimittel which grants STADA exclusive rights to sell, market and distribute Enzymatica’s common cold product ColdZyme in Germany. Stada is a global pharmaceutical company, headquartered in Germany, with a strong presence in Europe and leading positions in the cough and cold category in Germany, UK, and Russia. “We […]

Agreement - January 28, 2016

Enzymatica and Zymetech sign agreement

Swedish Enzymatica has signed an agreement to acquire Icelandic company Zymetech via a non-cash issue. This acquisition gives Enzymatica international exclusive rights to a patent-protected enzyme, a key ingredient in ColdZyme Mouth Spray, as well as control over production of the enzyme, access to international research and development expertise and Zymetech’s portfolio. The capital contributed […]

Agreement - November 16, 2015

Enzymatica signs distribution agreement

Enzymatica has partnered with Esteve, a leading pharmaceutical company in Spain. The agreement provides Esteve with exclusive rights to sell, market and distribute ColdZyme to pharmacies in Spain and Andorra. The agreement covers Enzymatica’s products ColdZyme 20 ml and ColdZyme One Cold, 7 ml. In Spain the products will be sold under the co-brand Cortagrip/ColdZyme. “The […]

Agreement - October 13, 2014

Enzymatica expands in Denmark

Enzymatica has signed agreements with the pharmacy chain Pharma+ and the wellness chain Matas in Denmark to sell ColdZyme. From November this year, ColdZyme will be available on the Danish market, and thus in all of Scandinavia. “According to plan, we are expanding to our neighboring countries using our own sales organization, building a platform of […]

New Market - September 26, 2014

Enzymatica gets first order for veterinary products

The company’s partner Adartis Animal Health has placed a first order for the veterinary products that Enzymatica launched in the United States and Canada in July 2014. The order includes Kalvatin products to a value of about SEK 3 million. According to Enzymatica the order is expected to cover market needs for the next six to […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.